Logo Logo
Hilfe
Hilfe
Switch Language to English

Russell, Lucy Louise ORCID logoORCID: https://orcid.org/0000-0001-5023-5893; Bouzigues, Arabella ORCID logoORCID: https://orcid.org/0000-0002-0267-8590; Convery, Rhian S. ORCID logoORCID: https://orcid.org/0000-0002-9477-1812; Foster, Phoebe H. ORCID logoORCID: https://orcid.org/0000-0001-6300-6598; Ferry-Bolder, Eve ORCID logoORCID: https://orcid.org/0009-0006-5083-0901; Cash, David M. ORCID logoORCID: https://orcid.org/0000-0001-7833-616X; Van Swieten, John C. ORCID logoORCID: https://orcid.org/0000-0001-6278-6844; Jiskoot, Lize Corrine ORCID logoORCID: https://orcid.org/0000-0002-1120-1858; Seelaar, Harro ORCID logoORCID: https://orcid.org/0000-0003-1989-7527; Moreno, Fermin ORCID logoORCID: https://orcid.org/0000-0001-5200-3164; Sánchez-Valle, Raquel ORCID logoORCID: https://orcid.org/0000-0001-7750-896X; Laforce, Robert ORCID logoORCID: https://orcid.org/0000-0002-2031-490X; Graff, Caroline ORCID logoORCID: https://orcid.org/0000-0002-9949-2951; Masellis, Mario ORCID logoORCID: https://orcid.org/0000-0002-6244-2096; Tartaglia, Maria Carmela ORCID logoORCID: https://orcid.org/0000-0002-5944-8497; Rowe, James B. ORCID logoORCID: https://orcid.org/0000-0001-7216-8679; Borroni, Barbara ORCID logoORCID: https://orcid.org/0000-0001-9340-9814; Finger, Elizabeth ORCID logoORCID: https://orcid.org/0000-0003-4461-7427; Synofzik, Matthis ORCID logoORCID: https://orcid.org/0000-0002-2280-7273; Galimberti, Daniela ORCID logoORCID: https://orcid.org/0000-0002-9284-5953; Vandenberghe, Rik ORCID logoORCID: https://orcid.org/0000-0001-6237-2502; Mendonça, Alexandre de ORCID logoORCID: https://orcid.org/0000-0002-0488-1453; Butler, Christopher ORCID logoORCID: https://orcid.org/0000-0002-7502-9284; Gerhard, Alexander ORCID logoORCID: https://orcid.org/0000-0002-8071-6062; Ducharme, Simon ORCID logoORCID: https://orcid.org/0000-0002-7309-1113; Ber, Isabelle Le ORCID logoORCID: https://orcid.org/0000-0002-2508-5181; Santana, Isabel ORCID logoORCID: https://orcid.org/0000-0002-8114-9434; Pasquier, Florence ORCID logoORCID: https://orcid.org/0000-0001-9880-9788; Levin, Johannes ORCID logoORCID: https://orcid.org/0000-0001-5092-4306; Sorbi, Sandro ORCID logoORCID: https://orcid.org/0000-0002-0380-6670; Otto, Markus ORCID logoORCID: https://orcid.org/0000-0003-4273-4267 und Rohrer, Jonathan Daniel ORCID logoORCID: https://orcid.org/0000-0002-6155-8417 (2025): Executive Function Deficits in Genetic Frontotemporal Dementia. In: Neurology Genetics, Bd. 11, Nr. 4, e200248 [PDF, 251kB]

[thumbnail of russell-et-al-2025-executive-function-deficits-in-genetic-frontotemporal-dementia.pdf]
Vorschau
Creative Commons: Namensnennung 4.0 (CC-BY)
Veröffentlichte Version

Abstract

Background and Objectives

Executive dysfunction is a core feature of frontotemporal dementia (FTD). While there has been extensive research into such impairments in sporadic FTD, there has been little research in the familial forms.

Methods

Seven hundred fifty-two individuals were recruited in total: 214 C9orf72; 205 progranulin (GRN) and 86 microtubule associated protein tau (MAPT) mutation carriers, stratified into asymptomatic, prodromal, and fully symptomatic; and 247 mutation-negative controls. Attention and executive function were measured using the Weschler Memory Scale-Revised (WMS-R) Digit Span Backwards (DSB), Wechsler Adult Intelligence Scale-Revised Digit Symbol task, Trail Making Test Parts A and B, and the Delis-Kaplan Executive Function System Color Word Interference Test. Linear regression models with bootstrapping were used to assess differences between groups. Correlation of task score with disease severity was also performed, as well as an analysis of the neuroanatomical correlates of each task.

Results

Fully symptomatic C9orf72, GRN, and MAPT mutation carriers were significantly impaired on all tasks compared with controls (all p < 0.001), except on the WMS-R DSB in the MAPT mutation carriers (p = 0.147). While asymptomatic and prodromal C9orf72 individuals also demonstrated differences compared with controls, neither the GRN or MAPT asymptomatic or prodromal mutation carriers showed significant deficits. All tasks were significantly correlated with disease severity in each of the genetic groups (all p < 0.001).

Discussion

Some individuals with C9orf72 mutations show difficulties with executive function from very early on in the disease and this continues to deteriorate with disease severity. By contrast, similar difficulties occur only in the later stages of the disease in GRN and MAPT mutation carriers. This differential performance across the genetic groups will be important in neuropsychological task selection in upcoming clinical trials.

Dokument bearbeiten Dokument bearbeiten